ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022 Post author:Cleo Sciscioli Post published:March 22, 2023 Post category:Newsroom Erytech provided a business and financial update for the fourth quarter and full year of 2022. You Might Also Like ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019 September 17, 2019 ERYTECH Receives USPTO Notice of Allowance for Patent Covering ERYCAPS Immunotherapy Technology March 15, 2016 ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer October 25, 2021
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019 September 17, 2019
ERYTECH Receives USPTO Notice of Allowance for Patent Covering ERYCAPS Immunotherapy Technology March 15, 2016
ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer October 25, 2021